ADAR1 Capital Management’s Perspective Therapeutics CATX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-69,985	Closed	-$698K	–	267
2024 Q2	$698K	Buy	69,985 +2,312	+3%	+$23.1K	0.13%	77
2024 Q1	$805K	Buy	67,673 +63,453	+1,504%	+$755K	0.18%	61
2023 Q4	$17K	Buy	+4,220	New	+$17K	0.01%	113